Cinnamon and its bioactive compounds may support brain function and slow cognitive impairment associated with neurodegenerative diseases, suggests a new review published in the journal Nutritional Neuroscience.
Cinnamon dietary supplements in Germany carrying health claims to
reduce blood sugar and help control type-2 diabetes should be
classed as 'medicinal products', and regulated as such, two federal
institutes have said.